BlackRock’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.82B | Sell |
19,887,111
-515,523
| -3% | -$169M | 0.1% | 174 |
|
|
2025
Q4 | $7.15B | Sell |
20,402,634
-130,635
| -0.6% | -$44.1M | 0.12% | 127 |
|
|
2025
Q3 | $6.63B | Buy |
20,533,269
+120,566
| +0.6% | +$37.5M | 0.12% | 137 |
|
|
2025
Q2 | $7.94B | Sell |
20,412,703
-898,312
| -4% | -$361M | 0.15% | 118 |
|
|
2025
Q1 | $9.27B | Buy |
21,311,015
+868,829
| +4% | +$349M | 0.19% | 91 |
|
|
2024
Q4 | $7.54B | Sell |
20,442,186
-591,440
| -3% | -$247M | 0.15% | 105 |
|
|
2024
Q3 | $10.9B | Buy |
21,033,626
+328,911
| +2% | +$176M | 0.23% | 68 |
|
|
2024
Q2 | $11.2B | Sell |
20,704,715
-215,981
| -1% | -$114M | 0.25% | 60 |
|
|
2024
Q1 | $10.8B | Sell |
20,920,696
-109,903
| -0.5% | -$54.7M | 0.25% | 61 |
|
|
2023
Q4 | $9.92B | Buy |
21,030,599
+536,585
| +3% | +$248M | 0.25% | 60 |
|
|
2023
Q3 | $8.92B | Buy |
20,494,014
+106,445
| +0.5% | +$48.3M | 0.26% | 60 |
|
|
2023
Q2 | $9.06B | Sell |
20,387,569
-454,694
| -2% | -$210M | 0.25% | 67 |
|
|
2023
Q1 | $9.58B | Sell |
20,842,263
-713,141
| -3% | -$339M | 0.28% | 60 |
|
|
2022
Q4 | $11.1B | Buy |
21,555,404
+506,029
| +2% | +$257M | 0.35% | 46 |
|
|
2022
Q3 | $9.56B | Sell |
21,049,375
-722,795
| -3% | -$346M | 0.33% | 47 |
|
|
2022
Q2 | $10.5B | Buy |
21,772,170
+266,312
| +1% | +$132M | 0.34% | 49 |
|
|
2022
Q1 | $10.6B | Buy |
21,505,858
+31,405
| +0.1% | +$14.4M | 0.28% | 59 |
|
|
2021
Q4 | $9.95B | Sell |
21,474,453
-180,422
| -0.8% | -$75.9M | 0.25% | 65 |
|
|
2021
Q3 | $8.07B | Buy |
21,654,875
+86,326
| +0.4% | +$32.8M | 0.23% | 78 |
|
|
2021
Q2 | $8.23B | Sell |
21,568,549
-538,279
| -2% | -$206M | 0.23% | 75 |
|
|
2021
Q1 | $7.94B | Sell |
22,106,828
-306,981
| -1% | -$98.7M | 0.23% | 75 |
|
|
2020
Q4 | $7.2B | Sell |
22,413,809
-462,547
| -2% | -$142M | 0.23% | 74 |
|
|
2020
Q3 | $6.14B | Buy |
22,876,356
+127,999
| +0.6% | +$34.4M | 0.23% | 81 |
|
|
2020
Q2 | $5.98B | Buy |
22,748,357
+390,241
| +2% | +$104M | 0.24% | 77 |
|
|
2020
Q1 | $5.08B | Sell |
22,358,116
-183,976
| -0.8% | -$50.1M | 0.25% | 73 |
|
|
2019
Q4 | $6.81B | Sell |
22,542,092
-225,618
| -1% | -$62.1M | 0.26% | 69 |
|
|
2019
Q3 | $5.47B | Buy |
22,767,710
+41,860
| +0.2% | +$11.5M | 0.23% | 76 |
|
|
2019
Q2 | $6.41B | Buy |
22,725,850
+708,538
| +3% | +$194M | 0.27% | 66 |
|
|
2019
Q1 | $6.32B | Sell |
22,017,312
-1,415,427
| -6% | -$409M | 0.28% | 63 |
|
|
2018
Q4 | $6.15B | Sell |
23,432,739
-71,616
| -0.3% | -$19.7M | 0.31% | 57 |
|
|
2018
Q3 | $6.44B | Buy |
23,504,355
+51,481
| +0.2% | +$13.4M | 0.28% | 62 |
|
|
2018
Q2 | $5.58B | Buy |
23,452,874
+856,345
| +4% | +$198M | 0.26% | 67 |
|
|
2018
Q1 | $4.96B | Buy |
22,596,529
+596,099
| +3% | +$140M | 0.24% | 72 |
|
|
2017
Q4 | $4.95B | Sell |
22,000,430
-782,302
| -3% | -$167M | 0.24% | 75 |
|
|
2017
Q3 | $4.33B | Buy |
22,782,732
+107,565
| +0.5% | +$20.5M | 0.22% | 83 |
|
|
2017
Q2 | $4.27B | Sell |
22,675,167
-1,778
| -0% | -$319K | 0.23% | 81 |
|
|
2017
Q1 | $3.75B | Buy |
22,676,945
+21,914,321
| +2,874% | +$3.49B | 0.21% | 88 |
|
|
2016
Q4 | $110M | Sell |
762,624
-40,540
| -5% | -$5.43M | 0.16% | 147 |
|
|
2016
Q3 | $101M | Sell |
803,164
-16,903
| -2% | -$2.18M | 0.14% | 159 |
|
|
2016
Q2 | $108M | Sell |
820,067
-22,097
| -3% | -$3.02M | 0.16% | 141 |
|
|
2016
Q1 | $117M | Sell |
842,164
-177,961
| -17% | -$23.8M | 0.19% | 112 |
|
|
2015
Q4 | $142M | Buy |
1,020,125
+66,914
| +7% | +$9.22M | 0.21% | 103 |
|
|
2015
Q3 | $133M | Buy |
953,211
+103,509
| +12% | +$15.6M | 0.21% | 101 |
|
|
2015
Q2 | $139M | Sell |
849,702
-64,907
| -7% | -$10.4M | 0.21% | 106 |
|
|
2015
Q1 | $141M | Buy |
914,609
+107,122
| +13% | +$15.3M | 0.2% | 112 |
|
|
2014
Q4 | $101M | Sell |
807,487
-28,249
| -3% | -$3.49M | 0.15% | 158 |
|
|
2014
Q3 | $100M | Buy |
835,736
+30,351
| +4% | +$3.48M | 0.15% | 153 |
|
|
2014
Q2 | $86.7M | Sell |
805,385
-24,592
| -3% | -$2.53M | 0.13% | 181 |
|
|
2014
Q1 | $82.6M | Sell |
829,977
-342,152
| -29% | -$30.9M | 0.13% | 166 |
|
|
2013
Q4 | $108M | Buy |
1,172,129
+175,378
| +18% | +$15.6M | 0.18% | 128 |
|
|
2013
Q3 | $83.3M | Buy |
996,751
+385,019
| +63% | +$33M | 0.16% | 148 |
|
|
2013
Q2 | $50.1M | Buy |
+611,732
| New | +$45.8M | 0.1% | 214 |
|
Other funds holding ELV
VCM
VPM
BlackRock's ELV Position: Q1 2026 in Review
BlackRock reduced its Elevance Health (ELV) stake by 2.5% in Q1 2026, selling an estimated $169M and leaving 19,887,111 shares worth $5.82B. The position accounts for 0.1% of the portfolio, ranked #174.
BlackRock first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.2B in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- BlackRock held 19,887,111 shares of Elevance Health worth $5.82B as of Q1 2026.
- BlackRock sold 515,523 Elevance Health shares in Q1 2026, an estimated $169M.
- Elevance Health made up 0.1% of BlackRock's portfolio in Q1 2026, its #174 holding.
- BlackRock first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- BlackRock's Elevance Health position peaked at $11.2B in Q2 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.